RNAseq analysis of hippocampal tissue from MTLE patients revealed potential molecules that may play crucial role in the pathogenesis of MTLE.
FN1 is central in our network analysis and demands further validation in serum and CSF samples for its potential as biomarker.
Three major hubs identified include molecules involved in modulation of neuronal networks, synaptic transmission, and neuroinflammation.
These hubs support the intrinsic severity hypothesis of pharmacoresistance.